Chinese Medicine in Treatment of A Patient with Acute Extensive Anterior Myocardial Infarction Complicated by Shock after Percutaneous Coronary Intervention

  • Shi-bao Li
  • Jin Sheng
  • Qi Zhou
  • Wen-long Xing
  • Hong-xu Liu
  • Wen-xian Liu
Case Report
  • 2 Downloads

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    De Luca L, Olivari Z, Farina A, Gonzini L, Lucci D, Chiara AD, et al. Temporal trends in the epidemiology, management, and outcome of patients with cardiogenic shock complicating acute coronary syndromes. Eur J Heart Fail 2015;17:1124–1132.CrossRefPubMedGoogle Scholar
  2. 2.
    Dushen T, Jim N, Ajay J. Management of cardiogenic shock complicating acute coronary syndromes. Heart 2013;99:1614–1623.CrossRefGoogle Scholar
  3. 3.
    Biswajit K, Igor DG, Sukhdeep SB, Gary M, Pranav L. The percutaneous ventricular assist device in severe refractory cardiogenic shock. J Am Coll Cardiol 2011;57:688–696.CrossRefGoogle Scholar
  4. 4.
    Ibanez B, James S, Agewall S, Antunes M, Bucciarelli-Ducci C, Bueno H, et al. 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The task force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2017;1–66.Google Scholar
  5. 5.
    Chinese Society of Cardiology, Editorial Board of Chinese Journal of Cardiology. Guideline of diagnosis and treatment of ST-segment elevation myocardial infarction. Chin J Cardiol (Chin) 2015;43:380–393.Google Scholar
  6. 6.
    Li J, Li X, Wang Q, Hu S, Wang YF, Frederick AM, et al. ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute MyocardialInfarction Study): a retrospective analysis of hospital data. Lancet 2015;385:441–451.CrossRefPubMedGoogle Scholar
  7. 7.
    Chinese Study Group for Cardiology (and CEI-AMI research). Controlled clinical trial of AMI treated with captopril by Chinse study on cardiology: a review of 14,962 cases. Chin J Cardioly (Chin) 1997;25:245–249.Google Scholar
  8. 8.
    Shang JJ, Shi H, Zhou Q, Gao W, Liu HX. A study of prognosis, outcome, and changing tendency of hospitalized AMI patients in Beijing third-grade A-level traditional Chinese medicine hospitals from 1999 to 2008. Evid Based Complement Alternat Med 2012;2012:837194.PubMedPubMedCentralGoogle Scholar
  9. 9.
    Liu HX, Gao W, Zhao D, Shang JJ, Sun JY. Investigation of hospitalization condition of AMI patients in 13 TCM and Western medicine hospitals in Beijing. Chin J Cardiol 2010;38:306–310.Google Scholar
  10. 10.
    Tian JF, Li JD, Lei Y, Wang SR, Shang JJ, Liu HX. Investigation of clinical manifestations and treatment of AMI patients in 26 class A tertiary hospitals in China. Chin J Integr Tradit West Med (Chin) 2012;32:329–332.Google Scholar
  11. 11.
    Wang PL, Zhang L, Wang SL, Yang QN, Gao ZY, Du JP, et al. Long-term follow-up of Chinese herbal medicines combined with conventional treatment in patients with acute coronary syndrome after percutaneous coronary intervention: A multicenter randomized controlled trial. Chin J Integr Med 2017;23:740–746.CrossRefPubMedGoogle Scholar
  12. 12.
    Luo J, Xu H, Yang G, Qiu Y, Liu J, Chen K. Oral Chinese proprietary medicine for angina pectoris: an overview of systematic reviews/meta-analyses. Complement Ther Med 2014;22:787–800.CrossRefPubMedGoogle Scholar
  13. 13.
    Luo J, Xu H. Outcome measures of Chinese herbal medicine for coronary heart disease: an overview of systematic reviews. Evid Based Complement Alternat Med 2012;2012:927392.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Liu HX. Three methods of managing heart in Beijing TCM. Beijing J Trad Chin Med 2015;34:171–172.Google Scholar
  15. 15.
    Xu XR, Wei ZZ, Xu XG, Wei YX, Gao YH, Huang LJ. Clinical observation of 30 cases of congestive heart-failure treated with heart failure medicament. J Tradit Chin Med 1983;11:25–26.CrossRefGoogle Scholar
  16. 16.
    Dai M, Wen QX, He JR, Wang ZY, Wang J, Zhang DY. Infl uence of heart failure medicament on angiotensin-ANF and N-end pro-brain natriuretic peptide of AMI patients. Chin J Integr Trad West Med (Chin) 2006;26:888–891.Google Scholar
  17. 17.
    Liu HX, Jin M, Wang ZY, Deng XR, Qin SM, Wang YM, et al. Clinical observation of 113 cases of unstable angina (blood-stasis pattern) treated by Shenyuan Decoction. J Tradit Chin Med 1999;4:219–221.Google Scholar
  18. 18.
    Liu HX, Li AY, Xie XR, Wu B, Shang JJ. Influence of prepared Shenyuan Pill on the MDA and SOD level of rat with myocardial ischemia/reperfusion. Chin J Microcircul (Chin) 2011;21;80–83.Google Scholar
  19. 19.
    Liu HX. Consensus of TCM experts on the treatment of CI in perioperative period by percutaneous coronary intervention. Chin J Integr Tradit West Med (Chin) 2017;37:389–393.Google Scholar
  20. 20.
    Chu FY, Liu W, Liu HX. Influence of qi tonifying and stasis-expelling method on the miR_24 expression and myocardial apoptosis of AMI rats. World Chin Med (Chin) 2016;11:392–394.Google Scholar

Copyright information

© Chinese Association of the Integration of Traditional and Western Medicine 2018

Authors and Affiliations

  • Shi-bao Li
    • 1
  • Jin Sheng
    • 2
  • Qi Zhou
    • 1
  • Wen-long Xing
    • 1
  • Hong-xu Liu
    • 1
  • Wen-xian Liu
    • 2
  1. 1.Department of Cardiovascular, Beijing Hospital of Traditional Chinese MedicineCapital Medical UniversityBeijingChina
  2. 2.Department of Cardiac Care Unit, Beijing Anzhen HospitalCapital Medical UniversityBeijingChina

Personalised recommendations